Corporate News: Lci Industries and Related Market Developments
Lci Industries (LCII) closed the trading session on Friday, 23 October 2026, at a 4.15 % gain. At 10:21 PM Central Europe, one share traded for USD 84.87.
- Shares outstanding: 24.3 million.
- Market capitalization: USD 2 billion.
- 24‑hour volume: USD 39.5 million.
- Month‑end performance: 1.85 % increase from the previous month.
- 200‑day simple moving average: USD 112.50.
- 52‑week high: USD 159.66 (recorded 02 December 2026).
- 52‑week low: USD 77.58 (recorded 10 December 2026).
Recent Disclosure
On 22 October 2026, Lci Industries filed an 8‑K with the Securities and Exchange Commission. The filing announced that the company will release its third‑quarter 2026 earnings on 5 November 2026. The filing includes a press release that outlines the timing of the earnings release, the associated conference call, and a webcast. Investors can access the presentation and a replay of the call via the company’s website or by dialing the numbers provided in the filing. The company expects a hold time of up to fifteen minutes due to high traffic during the earnings period.
Lci Industries highlighted its global leadership through its Lippert subsidiary, reaffirming its commitment to innovation, advanced manufacturing, and customer experience. The disclosure was made in compliance with Regulation FD and includes the company’s financial statements and exhibits.
Market Activity of Related Stocks (Last 24 Hours)
| Ticker | Current Price (USD) | % Change | Market Cap (USD bn) | PE Ratio |
|---|---|---|---|---|
| PURR (Hyperliquid Strategies) | 8.78 | +5.14 % | 2.4 | 3.62 |
| PBI (Pitney Bowes) | 17.34 | +0.80 % | 2.4 | — |
| SUPN (Supernus Pharmaceuticals) | 40.70 | +2.09 % | 2.4 | — |
| EROK (Eaglerock Land) | 18.24 | +0.16 % | 2.4 | — |
| RH (Rh) | 137.43 | +9.48 % | 2.4 | 22.76 |
Highlights
- Hyperliquid Strategies reported the purchase of 130,000 HYPE tokens on 22 October, bringing total holdings to 3.88 million units and a portfolio value near USD 30.5 billion. Cash positions were reduced by USD 10 million, leaving approximately USD 245 million.
- Supernus Pharmaceuticals received U.S. FDA seven‑year orphan‑drug exclusivity for its Parkinson’s disease treatment, ONAPGO, effective February 2025. A supplemental New Drug Application for a second ONAPGO supplier is under review, with potential approval expected by mid‑2027.
- Rh achieved a 9.48 % gain, driven by positive market sentiment and its price‑to‑earnings ratio of 22.76.
About Lci Industries
Lci Industries is headquartered in Elkhart, Indiana, and specializes in manufacturing recreational vehicles and equipment. Its product portfolio includes toolboxes, truck caps, running boards, side‑outs, mattresses, alignment systems, shock absorbers, power stabilizers, jacks, baggage doors, and sliders. The company markets its products globally and trades on the New York Stock Exchange. For further information, visit the company website at www.lci1.com .